-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TjiIl7zn1WcFj2++PaPFNG6Xq5VduMid0mGh4BfwUJsQ8Fh89pIjP/AE1RPEJEt4 0L6GBILcfieBM28YXVo0/w== 0001399490-08-000049.txt : 20080812 0001399490-08-000049.hdr.sgml : 20080812 20080812124122 ACCESSION NUMBER: 0001399490-08-000049 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080630 FILED AS OF DATE: 20080812 DATE AS OF CHANGE: 20080812 EFFECTIVENESS DATE: 20080812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 081008902 BUSINESS ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-677-5341 MAIL ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 redm2q08.txt REDMILE 13F HR 2Q08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2008 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group, LLC Address: One Ferry Building, Suite 255 San Francisco, CA 94111 13F File Number: 28- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415-677-5341 Signature, Place, and Date of Signing: Jeremy Green San Francisco, CA August 12, 2008 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form13F Information Table Entry Total: 34 Form13F Information Table Value Total: $161,941 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- ALIGN TECHNOLOGY INC COM 016255101 2307 220000 SH CALL DEFINED 220000 ALIGN TECHNOLOGY INC COM 016255101 4726 450510 SH DEFINED 450510 ALLOS THERAPEUTICS INC COM 019777101 10306 1491512 SH DEFINED 1491512 ALTUS PHARMACEUTICALS INC COM 02216N105 3538 795164 SH DEFINED 795164 AUXILIUM PHARMACEUTICALS INC COM 05334D107 6102 181500 SH DEFINED 181500 BIODEL INC COM 09064M105 4550 350000 SH DEFINED 350000 BIOMARIN PHARMACEUTICAL INC COM 09061G101 2608 90000 SH CALL DEFINED 90000 BIOMARIN PHARMACEUTICAL INC COM 09061G101 10865 374900 SH DEFINED 374900 CARDIOME PHARMA CORP COM NEW 14159U202 1545 175530 SH DEFINED 175530 ENZO BIOCHEM INC COM 294100102 5072 452042 SH DEFINED 452042 EV3 INC COM 26928A200 6006 633524 SH DEFINED 633524 EXACTECH INC COM 30064E109 2571 100000 SH DEFINED 100000 ILLUMINA INC COM 452327109 13580 155900 SH DEFINED 155900 INCYTE CORP COM 45337C102 2436 320081 SH DEFINED 320081 LEMAITRE VASCULAR INC COM 525558201 1930 641159 SH DEFINED 641159 MASIMO CORP COM 574795100 4397 128000 SH DEFINED 128000 MEDAREX INC COM 583916101 4894 740400 SH DEFINED 740400 NMT MED INC COM 629294109 1503 322570 SH DEFINED 322570 NORTHSTAR NEUROSCIENCE INC COM 66704V101 798 501992 SH DEFINED 501992 NXSTAGE MEDICAL INC COM 67072V103 4262 1110009 SH DEFINED 1110009 NXSTAGE MEDICAL INC COM 67072V103 1451 377778 SH DEFINED 377778 PHARMATHENE INC COM 71714G102 116 49100 SH DEFINED 49100 RESMED INC COM 761152107 7702 215500 SH DEFINED 215500 SAVIENT PHARMACEUTICALS INC COM 80517Q100 1265 50000 SH PUT DEFINED 50000 SCHERING PLOUGH CORP COM 806605101 8319 422500 SH DEFINED 422500 TERCICA INC COM 88078L105 3222 364920 SH DEFINED 364920 THIRD WAVE TECHNOLOGIES INC COM 88428W108 1924 172441 SH DEFINED 172441 THORATEC CORP COM NEW 885175307 9013 518297 SH DEFINED 518297 TOMOTHERAPY INC COM 890088107 2099 235085 SH DEFINED 235085 WELLCARE HEALTH PLANS INC COM 94946T106 1446 40000 SH DEFINED 40000 WRIGHT MED GROUP INC COM 98235T107 11019 387859 SH DEFINED 387859 WRIGHT MED GROUP INC COM 98235T107 397 14000 SH CALL DEFINED 14000 XENOPORT INC COM 98411C100 7246 185662 SH DEFINED 185662 ZIMMER HLDGS INC COM 98956P102 12726 187012 SH DEFINED 187012
-----END PRIVACY-ENHANCED MESSAGE-----